OLMA vs OLED: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

OLED has stronger fundamentals based on our AI analysis.

OLMA
Olema Pharmaceuticals, Inc.
SELL
75%
Confidence
VS
OLED
UNIVERSAL DISPLAY CORP \PA\
BUY
72%
Confidence

OLMA vs OLED Fundamental Comparison

Metric OLMA OLED
Revenue N/A $650.6M
Net Income $-162.5M $242.1M
Net Margin N/A 37.2%
ROE -33.9% 13.7%
ROA -30.5% 12.3%
Current Ratio 9.95x 10.06x
Debt/Equity 0.00x 0.00x
EPS $-1.87 $5.08

Green = Better metric | Red = Weaker metric

View Full OLMA Analysis →
View Full OLED Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OLMA vs AAPL OLED vs MSFT OLMA vs GOOGL OLED vs AMZN

OLMA vs OLED: Frequently Asked Questions

Is OLMA or OLED a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), OLED has stronger fundamentals. OLMA is rated SELL (75% confidence) while OLED is rated BUY (72% confidence). This is not investment advice.

How does OLMA compare to OLED fundamentally?

Olema Pharmaceuticals, Inc. has ROE of -33.9% vs UNIVERSAL DISPLAY CORP \PA\'s 13.7%. Net margins are N/A vs 37.2% respectively.

Which stock pays higher dividends, OLMA or OLED?

OLMA has a dividend yield of N/A or no dividend while OLED has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OLMA or OLED for long term?

For long-term investing, consider that OLMA has SELL rating with 75% confidence, while OLED has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OLMA vs OLED?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OLMA vs OLED, the AI consensus favors OLED based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.